Search results

Jump to navigation Jump to search

Page title matches

  • ...the brain, and important in regulating movement. A family of receptors ([[dopamine receptor]]s) mediate its action."<ref>{{MeSH}}</ref> ...lamus]] into the blood vessels of the median eminence, which transport the dopamine to the pituitary gland where it inhibits prolactin secretion from lactotrop
    11 KB (1,475 words) - 02:04, 22 August 2010
  • ...he behavior of cells."<ref name="MeSH-DopamineReceptors">{{MeSH|Receptors, Dopamine}}</ref> ...adenylate cyclase]].<ref name="MeSH-DopamineD1Receptors">{{MeSH|Receptors, Dopamine D1}}</ref>
    2 KB (304 words) - 07:50, 30 September 2009
  • 187 bytes (26 words) - 21:50, 19 September 2009
  • Auto-populated based on [[Special:WhatLinksHere/Dopamine]]. Needs checking by a human. {{r|Dopamine plasma membrane transport protein}}
    1 KB (148 words) - 16:03, 11 January 2010
  • 155 bytes (20 words) - 07:53, 30 September 2009
  • ...es within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake."<ref>{{MeSH}}</ref> Dopamine uptake inhibitors act on [[dopamine plasma membrane transport protein]]s.
    513 bytes (66 words) - 02:59, 7 October 2013
  • A drug that block the transport of dopamine into axon terminals or into storage vesicles within terminals.
    143 bytes (20 words) - 07:58, 30 September 2009
  • ...high affinity reuptake into presynaptic terminals and are the target of [[dopamine uptake inhibitor]]s."<ref>{{MeSH}}</ref> Dopamine plasma membrane transport proteins are the targets of [[dopamine uptake inhibitor]]s.
    580 bytes (71 words) - 03:31, 7 October 2013
  • 214 bytes (25 words) - 07:49, 30 September 2009

Page text matches

  • ...es within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake."<ref>{{MeSH}}</ref> Dopamine uptake inhibitors act on [[dopamine plasma membrane transport protein]]s.
    513 bytes (66 words) - 02:59, 7 October 2013
  • ...high affinity reuptake into presynaptic terminals and are the target of [[dopamine uptake inhibitor]]s."<ref>{{MeSH}}</ref> Dopamine plasma membrane transport proteins are the targets of [[dopamine uptake inhibitor]]s.
    580 bytes (71 words) - 03:31, 7 October 2013
  • Auto-populated based on [[Special:WhatLinksHere/Dopamine]]. Needs checking by a human. {{r|Dopamine plasma membrane transport protein}}
    1 KB (148 words) - 16:03, 11 January 2010
  • ...he behavior of cells."<ref name="MeSH-DopamineReceptors">{{MeSH|Receptors, Dopamine}}</ref> ...adenylate cyclase]].<ref name="MeSH-DopamineD1Receptors">{{MeSH|Receptors, Dopamine D1}}</ref>
    2 KB (304 words) - 07:50, 30 September 2009
  • Dopamine antagonist mainly used to treat schizophrenia and some other psychoses
    115 bytes (14 words) - 04:14, 1 October 2008
  • *{{CZ:Ref:Björklund 2007 Dopamine neuron systems in the brain: an update}}
    89 bytes (13 words) - 06:55, 30 January 2009
  • Dopamine antagonist used as an antiemetic agent and antipsychotic agent.
    108 bytes (13 words) - 16:44, 26 May 2023
  • A drug that block the transport of dopamine into axon terminals or into storage vesicles within terminals.
    143 bytes (20 words) - 07:58, 30 September 2009
  • ...M 2010 [http://content.nejm.org/cgi/content/full/362/9/779 Comparison of Dopamine and Norepinephrine in the Treatment of Shock]</ref> ...EJM 2010 [http://content.nejm.org/cgi/content/full/362/9/779 Comparison of Dopamine and Norepinephrine in the Treatment of Shock]</ref>
    2 KB (294 words) - 02:24, 11 June 2010
  • ...ith important members including [[epinephrine]], [[norepinephrine]], and [[dopamine]]
    205 bytes (21 words) - 19:45, 19 May 2010
  • Catecholamine plasma membrane transport proteins include [[dopamine plasma membrane transport protein]]s and [[norepinephrine plasma membrane t ...ransport proteins are the target of [[adrenergic uptake inhibitor]]s and [[dopamine uptake inhibitor]]s.
    706 bytes (82 words) - 05:29, 30 September 2009
  • ...homimetic drug, which enters the brain and triggers a cascading release of dopamine, serotonin and norepinephrine.
    179 bytes (22 words) - 21:15, 3 September 2009
  • ...region that contains the dopaminergic cell bodies of the mesocorticolimbic dopamine system, and which is a key part of the reward circuitry of the brain.
    198 bytes (29 words) - 10:32, 11 October 2010
  • ...s]] causes increased secretion of catecholamines. The most important are [[dopamine]], [[epinephrine]] and [[norepinephrine]].
    325 bytes (35 words) - 13:59, 17 June 2009
  • {{r|Dopamine}}
    242 bytes (27 words) - 17:14, 6 March 2024
  • {{r|Dopamine}}
    448 bytes (51 words) - 20:00, 25 October 2008
  • Berridge KC (2007). The debate over dopamine’s role in reward: the case for incentive salience ''Psychopharmacology'' de Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentola
    4 KB (553 words) - 12:33, 19 August 2012
  • ...erament<ref>Novelty Seeking Personality Trait. ({{OMIM|601696}})</ref><ref>Dopamine Receptor D4. ({{OMIM|126452}})</ref>.
    611 bytes (72 words) - 06:56, 28 January 2009
  • {{r|Dopamine}}
    589 bytes (57 words) - 14:17, 31 January 2009
  • ...urons of the [[arcuate nucleus]], which secrete [[dopamine]] to act on the dopamine-2 receptors (D2-R) of the lactotrophs, to inhibit prolactin secretion. [[T
    2 KB (255 words) - 09:49, 25 February 2009
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)